Macrogenics Inc (MGNX)

Dec 20, 2024

MacroGenics, Inc. (NASDAQ:MGNX) Shares Acquired by Fmr LLC - Defense World

Dec 20, 2024

Dec 19, 2024

MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Victoria Advocate

Dec 19, 2024

Dec 19, 2024

Faruqi & Faruqi Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - The Eastern Progress Online

Dec 19, 2024

Dec 17, 2024

MacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Charles Schwab Investment Management Inc. - Defense World

Dec 17, 2024

Dec 15, 2024

Analysts Set MacroGenics, Inc. (NASDAQ:MGNX) PT at $7.63 - MarketBeat

Dec 15, 2024

Dec 14, 2024

MacroGenics' SWOT analysis: oncology firm faces pipeline challenges, stock outlook mixed - Investing.com Australia

Dec 14, 2024

Dec 13, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online

Dec 13, 2024

Dec 13, 2024

Pharma Co. Brass Face Investor Suit Over Drug Trial Probe - Law360

Dec 13, 2024

Dec 12, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc.MGNX - The Eastern Progress Online

Dec 12, 2024

Dec 12, 2024

MacroGenics, Inc. Class Action: The Gross Law Firm Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - The Eastern Progress Online

Dec 12, 2024

Dec 11, 2024

Investors in MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online

Dec 11, 2024

Dec 10, 2024

MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Dec 10, 2024

Dec 10, 2024

MacroGenics, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - The Eastern Progress Online

Dec 10, 2024

Dec 10, 2024

Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - The Eastern Progress Online

Dec 10, 2024

Dec 08, 2024

Jacobs Levy Equity Management Inc. Purchases 147,438 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - MarketBeat

Dec 08, 2024

Dec 06, 2024

MGNX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MacroGenics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online

Dec 06, 2024

Dec 06, 2024

Investors who lost money on MacroGenics, Inc.(MGNX) should contact The Gross Law Firm about pending Class ActionMGNX - The Eastern Progress Online

Dec 06, 2024

Dec 06, 2024

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics - The Eastern Progress Online

Dec 06, 2024

Dec 06, 2024

MGNX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against MacroGenics, Inc. - The Eastern Progress Online

Dec 06, 2024

Dec 05, 2024

MacroGenics: A Productive Biotech With Growing PotentialStill Not A Buy - Seeking Alpha

Dec 05, 2024

Dec 02, 2024

MacroGenics to Participate in Upcoming Investor Conference - The Manila Times

Dec 02, 2024

Dec 02, 2024

MacroGenics CEO to Present at Evercore HealthCONx Conference, Spotlights Cancer Therapeutics - StockTitan

Dec 02, 2024

Nov 29, 2024

MGNX (Macrogenics) 3-Year Revenue Growth Rate : -20.90% (As of Sep. 2024) - GuruFocus.com

Nov 29, 2024

Nov 28, 2024

MGNX (Macrogenics) Owner Earnings per Share (TTM) : -1.32 (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

Nov 28, 2024

MGNX (Macrogenics) Growth Rank : 1 (As of Nov. 28, 2024) - GuruFocus.com

Nov 28, 2024